Severe anaphylaxis caused by intravenous anti‐cancer drugs

BACKGROUND: The incidence and risk factors of severe anaphylaxis by intravenous anti‐cancer drugs are unclear, whereas those of milder reactions have been reported. STUDY DESIGN: Electronic medical charts of cancer patients who have undergone intravenous chemotherapy between January 2013 and October...

Descripción completa

Detalles Bibliográficos
Autores principales: Horita, Nobuyuki, Miyagi, Etsuko, Mizushima, Taichi, Hagihara, Maki, Hata, Chiaki, Hattori, Yuki, Hayashi, Narihiko, Irie, Kuniyasu, Ishikawa, Hideyuki, Kawabata, Yusuke, Kitani, Yosuke, Kobayashi, Noritoshi, Kobayashi, Nobuaki, Kurita, Yusuke, Miyake, Yohei, Miyake, Kentaro, Oguri, Senri, Ota, Ichiro, Shimizu, Ayako, Takeuchi, Masanobu, Yamada, Akimitsu, Yamamoto, Kojiro, Yukawa, Norio, Masuda, Munetaka, Oridate, Nobuhiko, Ichikawa, Yasushi, Kaneko, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Researcher
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525120/
https://www.ncbi.nlm.nih.gov/pubmed/34505396
http://dx.doi.org/10.1002/cam4.4252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525120/
https://www.ncbi.nlm.nih.gov/pubmed/34505396
http://dx.doi.org/10.1002/cam4.4252

Ejemplares similares